A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- October 2014
- DOI:
- 10.1371/journal.pone.0108694
- Bibcode:
- 2014PLoSO...9j8694S